We are live on ! Find out more
AAM

Azzad Asset Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 38.47%
This Fund
S&P 500
This Quarter Est. Return
+11.49%
1 Year Est. Return
+38.47%
3 Year Est. Return
+100.53%
5 Year Est. Return
+132.43%
10 Year Est. Return
+597.52%
AUM
$745M
AUM Growth
+$68.8M
Cap. Flow
+$6.41M
Cap. Flow %
0.86%
Top 10 Hldgs %
15.77%
Holding
342
New
18
Increased
160
Reduced
132
Closed
14

Top Sells

Rank Stock Value
1
GNTX icon
Gentex
GNTX
+$2.68M
2
ITW icon
Illinois Tool Works
ITW
+$2.32M
3
CP icon
Canadian Pacific Kansas City
CP
+$2.22M
4
IT icon
Gartner
IT
+$1.98M
5
AMGN icon
Amgen
AMGN
+$1.63M

Sector Composition

Rank Sector Weight
1 Technology 30.9%
2 Healthcare 14.79%
3 Industrials 11.79%
4 Consumer Discretionary 10.85%
5 Consumer Staples 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITW icon
101
Illinois Tool Works
ITW
$82.4B
$2.59M 0.35%
10,487
-9,986
-49% -$2.32M
PNR icon
102
Pentair
PNR
$10.7B
$2.58M 0.35%
35,395
+1,359
+4% +$100K
COHR icon
103
Coherent
COHR
$56.2B
$2.55M 0.34%
37,387
AMT icon
104
American Tower
AMT
$81B
$2.55M 0.34%
8,727
+151
+2% +$41.3K
ISRG icon
105
Intuitive Surgical
ISRG
$133B
$2.55M 0.34%
7,086
-45
-0.6% -$15.5K
MTD icon
106
Mettler-Toledo International
MTD
$28.8B
$2.54M 0.34%
1,498
+17
+1% +$25.7K
DOCU
107
DocuSign
DOCU
$10.7B
$2.54M 0.34%
16,659
-497
-3% -$113K
IMO icon
108
Imperial Oil
IMO
$61.2B
$2.53M 0.34%
70,215
-18,699
-21% -$643K
UL icon
109
Unilever
UL
$137B
$2.52M 0.34%
41,648
+3,573
+9% +$212K
KO icon
110
Coca-Cola
KO
$373B
$2.5M 0.34%
42,238
+1,949
+5% +$109K
ROP icon
111
Roper Technologies
ROP
$38.9B
$2.47M 0.33%
5,014
+146
+3% +$69.5K
MASI
112
DELISTED
Masimo
MASI
$2.46M 0.33%
8,390
-38
-0.5% -$10.8K
EMR icon
113
Emerson Electric
EMR
$85.6B
$2.44M 0.33%
26,244
+1,301
+5% +$123K
BMY icon
114
Bristol-Myers Squibb
BMY
$132B
$2.43M 0.33%
39,039
+639
+2% +$37.5K
ROST icon
115
Ross Stores
ROST
$80.9B
$2.4M 0.32%
21,003
+5,824
+38% +$651K
AZTA icon
116
Azenta
AZTA
$1.37B
$2.39M 0.32%
23,164
-197
-0.8% -$21.4K
ZBRA icon
117
Zebra Technologies
ZBRA
$13.9B
$2.39M 0.32%
4,007
-90
-2% -$51.1K
SGEN
118
DELISTED
Seagen Inc. Common Stock
SGEN
$2.38M 0.32%
15,396
+32
+0.2% +$5.36K
GWRE icon
119
Guidewire Software
GWRE
$13.1B
$2.36M 0.32%
20,784
+1,381
+7% +$164K
AVB icon
120
AvalonBay Communities
AVB
$26.7B
$2.35M 0.32%
9,295
+3,536
+61% +$843K
SAP icon
121
SAP
SAP
$219B
$2.35M 0.31%
16,741
+3,036
+22% +$424K
SBUX icon
122
Starbucks
SBUX
$119B
$2.34M 0.31%
20,043
+209
+1% +$23.6K
NVO
123
Novo Nordisk
NVO
$206B
$2.33M 0.31%
41,666
-3,532
-8% -$191K
ABMD
124
DELISTED
Abiomed Inc
ABMD
$2.31M 0.31%
6,438
+1
+0% +$338
MKC icon
125
McCormick & Company Non-Voting
MKC
$13.8B
$2.29M 0.31%
23,672
+1,043
+5% +$88.8K

Similar funds

Azzad Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Azzad Asset Management held 342 positions worth $745M, up 10% from $677M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Azzad Asset Management's Q4 2021 filing shows 18 new, 160 increased, 132 reduced and 14 closed positions. Its largest new stake was Criteo S.A. Ordinary Shares: 68,415 shares worth $2.66M. The largest sale was Gentex, an estimated $2.68M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Azzad Asset Management's largest Q4 2021 buy was Criteo S.A. Ordinary Shares: 68,415 shares worth $2.66M.
  • Azzad Asset Management added most to AstraZeneca in Q4 2021, an estimated $1.79M increase.
  • Azzad Asset Management's biggest Q4 2021 reduction was Illinois Tool Works, cutting an estimated $2.32M.
  • Azzad Asset Management fully exited Gentex in Q4 2021, selling an estimated $2.68M.
  • Azzad Asset Management's ten largest holdings make up 16% of its $745M portfolio in Q4 2021.
  • Azzad Asset Management opened 18 new positions and closed 14 in Q4 2021.
  • Azzad Asset Management's portfolio value rose 10% quarter-over-quarter to $745M.

Based on Azzad Asset Management's 13F filing for Q4 2021, filed 1 Apr 2024.